ArticleMedicine2016

Erratum: A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer: Erratum.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.